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Abstract
Introduction Pulmonary embolism (PE) is one of the greatest
diagnostic challenges in prehospital emergency setting. Most
patients with suspected PE have a positive D-dimer and
undergo diagnostic testing. Excluding PE with additional non-
invasive tests would reduce the need for further imaging tests.
We aimed to determine the effectiveness of combination of
clinical probability and end-tidal carbon dioxide (PetCO2) for
evaluation of suspected PE with abnormal concentrations of D-
dimer in prehospital emergency setting.
Methods We assessed clinical probability of PE and PetCO2
measurement in 100 consecutive patients with suspected PE
and positive D-dimer in the field. PetCO2 > 28 mmHg was
considered as the best cut-off point. PE was excluded or
confirmed by hospital physicians in the University Clinical
Center Maribor by computer tomography (CT), ventilation/
perfusion scan echocardiography and pulmonary angiography.
Results PE was confirmed in 41 patients. PetCO2  had a
sensitivity of 92.6% (95% CI, 79 to 98%), a negative predictive
value of 94.2% (95% CI, 83 to 99%), a specificity of 83% (95%
CI, 71 to 91%) and a positive predictive value of 79.2% (95%
CI, 65 to 89%). Thirty-five patients (35%) had both a low (PE
unlikely) clinical probability and a normal PetCO2 (sensitivity:
100%, 95% CI: 89 to 100%) and twenty-eight patients (28%)
had both a high clinical probability (PE likely) and abnormal
PetCO2 (specificity: 93.2%, 95% CI: 83 to 98%).
Conclusions The combination of clinical probability and
PetCO2 may safely rule out PE in patients with suspected PE
and positive D-dimer in the prehospital setting.
Introduction
Pulmonary embolism (PE) is a common disorder with substan-
tial associated morbidity and mortality [1,2]. It typically has a
nonspecific clinical presentation and often poses a significant
diagnostic challenge [3,4]. Accurate diagnosis in the prehos-
pital emergency setting is critical because 30-day mortality in
patients in whom the diagnosis is initially missed is 17% [5].
Several non-invasive tests have been introduced to reduce the
need for further diagnostic tests in patients with suspected
PE. The D-dimer test is usually performed first because it can
safely rule out PE and thus, reduce the need for further testing
[6]. However, because of its poor specificity, especially in eld-
erly patients, patients with cancer, hospitalized patients and
pregnant women, the D-dimer test excludes PE in only 30% of
patients [7-11]. The first step in safely using the D-dimer test
is to determine the patient's risk of PE. The most frequently
used clinical prediction rule is the Canadian rule, developed by
Wells and colleagues as shown in Table 1[6,7]. This rule has
been validated extensively using both a three-category (low,
moderate or high clinical probability) and a two-category
scheme (PE likely or unlikely) [12,13]. Alternative non-invasive
tests that can be used in the prehospital setting are required.
Capnometry and capnography are reliable diagnostic and
prognostic tools for a variety of conditions [14-16]. PE signifi-
cantly decreases alveolar carbon dioxide (CO2) content [17-
19]. It obstructs blood flow to a normally ventilated area of
ALS: advanced life support; AUROC: area under the receiver operating characteristic curve; BLS: basic life support; CI: confidence interval; CO2: 
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lung, producing a locally high ventilation, low perfusion rela-
tion, therefore increasing alveolar dead space [20]. Gas
exhaled from this unperfussed lung unit contains little CO2 and
therefore reduces the partial pressure of end-tidal carbon diox-
ide (PetCO2) of the whole lung in relation to the partial pres-
sure of arterial CO2 (PaCO2). Alveolar dead space fraction
((arterial CO2 - end-tidal CO2)/arterial CO2) has insufficient
sensitivity to exclude PE safely [21-23]. Some previous stud-
ies demonstrated the use of a combination of alveolar dead
space fraction measurement and D-dimer testing, and this
combination has been suggested to be superior to either tool
used in isolation [21-23]. Sanchez and colleagues demon-
strated the use of a combination of alveolar dead space frac-
tion and clinical probability [24]. In recently published
guidelines on the diagnosis and management of acute PE,
authors concluded that negative D-dimer safely excluded PE
in patients with low clinical probability ('PE unlikely' patients).
The negative predictive value of D-dimer was high. In patients
with high clinical probability ('PE likely' patients) normal results
did not safely exclude PE. The positive predictive value of D-
dimer was low, so D-dimer was not useful for confirming PE
[25].
Therefore, we hypothesized that the combination of PetCO2
and clinical probability with positive D-dimer test could
improve diagnostic accuracy in the prehospital setting in
patients with suspected PE. We wanted to determine if the
combination of two level clinical probability assessment and
PetCO2 measurement could confirm or exclude PE in patients
with an abnormal D-dimer test.
The aim of this study is to determine whether PetCO2
improves sensitivity for exclusion of PE in unlikely patients with
abnormal D-dimer results, and confirms PE with high specifi-
city in PE likely patients in the prehospital setting.
Materials and methods
Setting
Between October 2004 and December 2008, this prospec-
tive cohort observational study was performed in the prehos-
pital emergency setting (Center for Emergency Medicine
Maribor, Slovenia, Europe). The study was approved by the
Ethical Review Board of the Ministry of Health of Slovenia. We
did not obtain patient consent as a part of the protocol. We
argued successfully to the Ethical Review Board that the pro-
tocol posed minimal risk to patients and the board deemed
consent not to be required. The study was conducted in the
city of Maribor and adjacent rural areas encompassing a pop-
ulation of 200,000 inhabitants spread over an area of 780 km2.
The emergency medical service system is accessed through a
single emergency number (112). The system includes two pre-
hospital emergency teams with advanced life support (ALS)
capability, two basic life support (BLS) teams, and during the
daytime - from April to October - a rescuer on a motorcycle.
Each ALS team is comprised of one emergency physician and
two additional personnel who are either registered nurses,
medical technicians, or a combination of the two; all with train-
ing in advanced cardiac life support. Each BLS team is com-
prised of two nurses or registered nurses and the motorcycle
rescuer who is a nurse or a registered nurse, all with BLS train-
ing and able to provide electrical defibrillation, chest compres-
sions, ventilation, and oxygenation before arrival of the ALS
team. If the call refers to a life-threatening emergency, the ALS
team is concomitantly dispatched. On occasion, the ALS team
is called by the BLS team after on site recognition of a life-
threatening emergency.
Patients
All consecutive patients presented with clinically suspected
PE and a positive D-dimer test were eligible for inclusion in the
study (n = 170).
Inclusion criteria were: age older than 18 years; a clinical sus-
picion of acute PE, defined as acute chest pain, new onset or
worsening dyspnea without other obvious causes, and/or a
collapse with the symptoms of obstructive shock; and a posi-
tive D-dimer test assessed by the rapid quantitative test -
CARDIAC D-Dimer measurements (≥ 500 mg/L).
Exclusion criteria were: inability to participate; ongoing antico-
agulation for other diseases (e.g. atrial fibrillation); patients
under intubation; history of renal insufficiency; and/or in the
final stages of a terminal illness.
Table 1
Clinical probability (the Wells score) of pulmonary embolism
Wells score*
Variable Points
Previous DVT or PE + 1.5
Recent surgery or immobilization + 1.5
Cancer + 1
Haemoptysis + 1
Heart rate > 100 beats/min + 1.5
Clinical signs of DVT + 3
Alternative diagnosis less likely than PE + 3
Clinical probability (3 levels) Total
Low 0-1
Intermediate 2-6
High > _7
Clinical probability (2 levels) Total
PE unlikely 0-4
PE likely > 4
*Wells score [7].
DVT = deep vein thrombosis; PE = pulmonary embolism.Available online http://ccforum.com/content/13/6/R196
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After prehospital care, all patients were admitted to the Univer-
sity Clinical Center Maribor and followed until discharge.
Design of the study
This prospective cohort observational study was performed in
the prehospital emergency setting (Center for Emergency
Medicine Maribor, Slovenia, Europe) between October 2004
and December 2008.
Clinical probability of PE (PE likely or unlikely) was assessed
using a prediction rule by Wells and colleagues (Table 1) and
was followed by plasma D-dimer test (Cardiac D-dimer meas-
urements - Roche Diagnostics, Mannheim, Germany). D-dimer
was measured in all patients with initial clinical suspicion of
acute PE, both in the PE likely and PE unlikely groups. The
components of the score by Wells and colleagues were col-
lected by prehospital emergency physicians and recorded in a
protocol. During initial evaluation (before application of medi-
cine), a 5 mL sample of venous blood was collected into a tube
containing calcium disodium edetate for the measurement of
D-dimer. The level of D-dimer was measured with a portable
automatic device (Cardiac Reader, Roche Diagnostics, Man-
nheim, Germany), and recorded in the paper collection form
(protocol). The patients with normal D-dimer concentration (<
0.5 μg/ml) were not included in the study. We analysed and
followed up only the patients with abnormal D-dimer results.
Arterial blood gas analysis and other laboratory tests were per-
formed in the hospital laboratory. PetCO2 measurements were
carried out in all patients with abnormal D-dimer concentra-
tions. PetCO2 was obtained by quantitative capnometry, per-
formed with a Lifepak 12 (Medtronic Physiocontrol, Corporate
Headquarters, Redmond, WA, USA); PetCO2 value (an aver-
age value of the first three measurements in the first minute
after nasal measurement) was registered. The final hospital
diagnosis of PE (at the University Clinical Center Maribor) was
confirmed by hospital physicians blinded to the values of
PetCO2 and prehospital D-dimer results, using the reference
standard definition for PE in accordance with instruments,
including computed tomography (CT), ventilation/perfusion
scan, echocardiography and pulmonary angiography. Prehos-
pital emergency physicians and physicians at admission to
hospital (emergency department of internal medicine) were
not blinded to the results of D-dimer and PetCO2 because
these are the routine tests in our prehospital emergency care.
In addition, the investigators did not collaborate in making the
final diagnosis.
Pulmonary embolism evaluation was considered positive by
satisfying one of the following conditions: 1) positive CT, 2)
high probability V/Q lung scan or 3) positive pulmonary angi-
ography.
Statistical analysis
Univariate comparison was made with chi-squared test for cat-
egorical variables and Student's t-test for continuous varia-
bles. Univariate analysis was performed for all variables
pertinent to diagnose PE, and multivariate analysis was per-
formed to identify potential predictor variables of a final diag-
nosis of PE (variables from univariate analysis with a P value
less than 0.05 for entry into model). The area under the
receiver operating characteristic curve (AUROC) was used for
diagnostic accuracy of quantitative capnometry in confirming
PE in patients with positive D-dimer in the prehospital emer-
gency setting.
To evaluate the diagnostic performances of the PetCO2 test-
ing, sensitivity, specificity, positive and negative predictive val-
ues and their 95% confidence intervals (CI) were calculated
according to standard methods for proportions. Calculation
was performed for the whole group of patients tested, then
according to high (PE likely) or low (PE unlikely) clinical prob-
ability. Sensitivity was defined as the number of patients with
a positive result on PetCO2 divided by the number of patients
with PE. Specificity was defined as the number of patients with
a negative result of PetCO2 divided by the number of patients
without PE. All analyses were performed using SPSS 15.0 for
Windows (SPSS Institute, Chicago, IL, USA).
Results
Between October 2004 and December 2008, 131 patients
with suspected PE and a positive D-dimer test were enrolled.
Thirty-one patients were excluded because of anticoagulant
treatment for more than 48 hours before inclusion (n = 10),
inability to participate (n = 12) and receiving mechanical ven-
tilation (n = 9). Recruitment, exclusion and subsequent group-
ing of all patients are shown in Figure 1. The baseline clinical
and demographic variables of the study populations are dis-
played in Table 2. For the identification of the final diagnosis of
PE, we examined 37 variables (Table 2) and 11 variables
remained statistically significant after analysis. Variables from
univariate analysis (with P < 0.05) were included into a model
of multivariable analysis with logistic regression for identifica-
tion of potential predictor variables of a final diagnosis of PE.
Finally, after multivariable logistic regression analysis six varia-
bles were defined as independent predictor variables: PaCO2,
partial pressure of arterial oxygen (PaO2), D-dimer, PetCO2,
cyanosis, previous deep vein thrombosis and/or PE (Table 3).
PE was diagnosed during the initial diagnostic work up by a
positive spiral CT in 78 patients, a high probability ventilation/
perfusion scan in 20 patients and pulmonary angiography in 2
patients. These patients were considered to have PE for the
analysis of the diagnostic accuracy of PetCO2. Thus, PE was
confirmed in 41 patients (41%) and excluded in the remaining
59 patients (59%) on the basis of the results of initial diagnos-
tic work up. Among 31 patients who met exclusion criteria for
PE, no one had confirmed diagnosis of PE. Five of 41 patients
with PE died, because of recurrent PE during hospitalization.
Two of 59 patients without PE died: 1 of septic shock and 1
of cardiac arrest.Critical Care    Vol 13 No 6    Rumpf et al.
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Figure 1
The flow diagram of recruitment, exclusion and subsequent grouping of all patients in the study The flow diagram of recruitment, exclusion and subsequent grouping of all patients in the study. PE = pulmonary embolism; PetCO2 = partial pres-
sure of end-tidal carbon dioxide.
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Table 2
Univariate analysis for all demographic and clinical variables pertinent to diagnosis of pulmonary embolism (n = 100)
Variable** PE
(n = 41)
No PE
(n = 59)
P value#
Demographic data
Age (mean ± SD) 71 ± 13 70 ± 11 0.752
Gender (M/F) 15/26 33/26 0.057
Previous DVT or PE (Y/N) 10/31 2/57 0.001
Smoker (Y/N) 5/36 25/34 0.001
Thromboembolic risk factors
Surgery or fracture within 1 month (Y/N) 9/32 6/53 0.105
Malignancy (Y/N) 10/31 6/53 0.056
Hormone therapy (Y/N) 2/39 1/58 0.359
Palpitation (Y/N) 8/33 18/41 0.218
Calf pain (Y/N) 9/32 10/49 0.531
Relatively asymptomatic (Y/N) 2/39 0/59 0.087
Thrombophlebitis (Y/N) 2/39 0/59 0.087
Unilateral leg swelling (Y/N) 6/35 2/57 0.041
Cyanosis (Y/N) 10/31 1/58 < 0.001
Chronic venous insufficiency (Y/N) 1/40 2/57 0.784
COPD (Y/N) 10/31 10/49 0.360
Heart failure (Y/N) 18/23 38/21 0.042
Hemiparesis (Y/N) 2/39 4/55 0.694
Immobilization (Y/N) 4/37 2/57 0.187
Suspected DVT 6/35 3/56 0.101
Family history of venous thromboembolism (Y/N) 2/39 0/59 0.087
Clinical symptoms and signs
Syncope (Y/N) 19/22 28/31 0.912
Pulse (1/min) 104 ± 18 93 ± 13 0.001
PaCO2 (mmHg) 36 ± 4 41 ± 6 < 0.001
PaO2 (mmHg) 9 ± 1 12 ± 1 < 0.001
Dyspnea (sudden onset) (Y/N) 39/2 57/2 0.709
Pleural chest pain (Y/N) 27/14 48/11 0.078
Hemoptysis (Y/N) 2/39 2/57 0.709
Sweating (Y/N) 4/37 3/56 0.368
SpO2 (%) 87 ± 6 88 ± 7 0.655
D-Dimer (mg/L) 2010 ± 804 1238 ± 692 < 0.001
Cough (Y/N) 12/29 18/41 0.894
PetCO2 (mmHg) 25 ± 2 32 ± 4 < 0.001
Body temperature (°C) 36.8 ± 0.4 36.9 ± 0.4 0.641
Systolic BP (mmHg) 113 ± 21 122 ± 30 0.116
Diastolic BP (mmHg) 71 ± 12 71 ± 16 0.794
Crackles on auscultation (Y/N) 18/23 25/34 0.879
Respiratory rate (1/min) 23 ± 5 21 ± 2 0.024
BP = blood pressure; COPD = chronic obstructive pulmonary disease; DVT = deep venous thrombosis; F = female; M = male; N = no; PaCO2 = 
partial pressure of arterial carbon dioxide; PaO2 = partial pressure of arterial oxygen; PE = pulmonary embolism; PetCO2 = partial pressure of end-
tidal carbon dioxide; SD = standard deviation; SpO2 = peripheral oxygen saturation; Y = yes;
** Results are presented as mean +/- standard deviation for normally distributed data or ratio or percentage of other variables.
# Univariate comparison was made with chi-square test for categorical variables and t test for continuous variables. For evaluation of diagnostic 
accuracy, patients were divided into two groups: with PE and without PE.Critical Care    Vol 13 No 6    Rumpf et al.
Page 6 of 9
(page number not for citation purposes)
End-tidal carbon dioxide
Receiver operating characteristics analysis selected 28
mmHg as the optimal cut-off for PetCO2 (Figure 2). The
AUROC curve for PetCO2 is 0.929 (95% CI = 0.881 to
0.977).
Thirty-eight of the 41 patients (92.6%) with PE had abnormal
PetCO2 of less than 28 mmHg compared with 10 of the 59
patients (16.9%) without PE. A PetCO2 above 28 mmHg
excluded PE with a sensitivity of 92.6% (95% CI = 79 to
98%), a negative predictive value of 94.2% (95% CI = 83 to
99%), a specificity of 83% (95% CI = 71 to 91%) and a pos-
itive predictive value of 79.2% (95% CI = 65 to 89%).
Thirty-five patients had a low (PE unlikely) clinical probability
and PetCO2 above 28 mmHg. This combination excluded PE
with a sensitivity of 100% (95% CI = 89 to 100%), a negative
predictive value of 100% (95% CI = 88 to 100%). Twenty-
eight patients had a high clinical probability (PE likely) and a
PetCO2 below 28 mmHg. This combination had a specificity
of 93.2% (95% CI = 83 to 98%) and a sensitivity of 58.5%
(95% CI = 42 to 73%) for PE (Table 4).
Discussion
In our study, we have demonstrated that the combination of
PetCO2 of more than 28 mmHg and low clinical probability
(PE unlikely) is a potentially safe method for excluding PE in
patients with suspected PE and positive D-dimer test in the
prehospital setting. The results also suggest that the measure-
ment of PetCO2 alone has a lower negative predictive value
(94%; 95% CI = 83 to 99%) than the previously mentioned
combination of tests (100%; 95% CI = 89 to 100%).
In our study we found that the combination of high clinical
probability (PE likely) and a PetCO2 of less than 28 mmHg had
93.2% specificity (95% CI = 83 to 98%) for the confirmation
of PE.
Some studies [21-23] have evaluated the diagnostic accuracy
of capnography in patients with suspected PE. The multi-
center study by Kline and colleagues [21] calculated sensitiv-
ity as 67.2% (95% CI = 55.0 to 77.5%) and specificity as
76.3% (95% CI = 71.2 to 85.6%). Rodger and colleagues
[22] calculated sensitivity as 79.5% (95% CI = 63.5 to
90.7%) and a specificity of 70.3% (95% CI = 61.2 to 78%).
A negative predictive value varied from 90.7% [22] to 91.9%
[21]. Hogg and colleagues [23] calculated sensitivity as
100% (95% CI = 84.5 to 100%) but a low specificity of
22.7% (95% CI = 18.8 to 27.2%). The combination of a nor-
mal alveolar dead space fraction and normal D-dimer concen-
tration excluded PE with a sensitivity ranging from 90.5% to
98.4% [21-23]. Sanchez and colleagues [24] combined alve-
olar dead space fraction and clinical probability assessment in
patients with a positive D-dimer. The combination of a normal
alveolar dead space fraction and a low clinical probability
excluded PE with a sensitivity of 99.1% (95% CI = 94.9 to
100%) and a negative predictive value of 97.8% (95% CI =
88.2 to 99.9%). Our study shows similar results as this study,
the difference being that we combined PetCO2 and clinical
probability assessment in patient with a positive D-dimer.
Our study suggests that a simple method of nasal measure-
ment of PetCO2 in combination with clinical evaluation can
safely exclude PE without blood gas analysis and calculations
of PaCO2 - PetCO2 gradient (unpractical for diagnostics in the
field).
What impact do these results have on patient care, and what
patient benefit is derived from the out-of-hospital study? The
primary goal of our observational, prospective study was to
find out the diagnostic rule of PetCO2 in patients with sus-
pected PE and abnormal D-dimer results. The study showed
that these results could be useful in the emergency depart-
ment. Corwin and colleagues [26] and Hirai and colleagues
[27] reported that emergency physicians did not use D-dimer
effectively to determine the need for CT or angiography in the
evaluation of acute PE. The use of quantitative D-dimer in com-
bination with PetCO2  in the prehospital setting would
decrease unnecessary imaging and irradiation, costs and time
for patients seen in the admission department. The results
from the field can help in diagnostic decisions. The prehospital
emergency physician can organize direct transport from the
field to pulmonary vascular imaging. Squizzato and colleagues
[28] showed in a meta-analysis that 928 patients with sympto-
Table 3
Logistic regression analysis of factors used for confirmation of 
PE in patients with positive D-dimer in prehospital emergency 
setting
Factor OR (95% CI)** P value#
PaCO2 9.8 (4.2-15.1) < 0.001
PaO2 14.1(6.9-27.4) < 0.001
D-dimer 15.3 (6.3-25.8) < 0.001
PetCO2 7.4 (2.8-17.8) < 0.001
Cianosis 6.2 (1.8-13.1) 0.013
Previous DVT or/and PE 6.8 (1.5-11.7) 0.021
Smoker 0.14 (0.04-0.34) < 0.001
CI = confidence interval; DVT = deep venous thrombosis; PaCO2 = 
partial pressure of arterial carbon dioxide; PaO2 = partial pressure of 
arterial oxygen; PE = pulmonary embolism; PetCO2 = partial 
pressure of end-tidal carbon dioxide; OR = odds ratio.
** Univariable screening was performed on clinical, historical and 
biochemical variables to identify potential predictors of PE. Odds 
ratios for the presence of PE were generated and expressed with 
95% CI.
# Multivariable analysis with logistic regression was used to identify 
potential predictor variables of a final diagnosis of PE (variables from 
univariate analysis with P < 0.05. For entry into model).Available online http://ccforum.com/content/13/6/R196
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matic PE were treated completely as outpatients or dis-
charged early.
In previous recommendations for the diagnosis of PE [25],
bedside echocardiography was recommended for high-risk
PE (presence of shock or persistent hypotension). Mansencal
and colleagues [29] found that echocardiography (using a
portable ultrasound device) is a reliable method for screening
patients with suspected PE, especially in patients with dysp-
nea or with high clinical probability. The prehospital point-of-
care ultrasound is reality [30], and its findings can help in
thrombolytic therapy in the field. Thrombolytic therapy is the
first-line treatment in patients with high-risk PE presenting with
cardiogenic shock and/or persistent arterial hypotension
because it rapidly exerts beneficial effects on hemodynamic
parameters.
We used the prediction rule described by Wells and col-
leagues. There is no clear difference in diagnostic perform-
ance between using another clinical prediction rules, but the
score by Wells and colleagues has been more extensively val-
idated.
However, this study has some limitations. Firstly, prehospital
emergency physicians and hospital physicans at admission
were not blinded to the values of PetCO2 and the D-dimer test
as assessed by the rapid quantitative test because capnome-
try represents the routine procedure in our prehospital man-
agement.
Secondly, the study was realized in a single emergency center
with a relatively small sample size. Thirdly, all patients would
have had the reference standard (CT, pulmonary angiography
or a normal ventilation/perfusion scan result). Finally, severe
additional factors may have an impact of the reliability of
PetCO2 (some patient hyperventilated, had periodic breathing
or had ventilation/perfusion mismatch).
Conclusions
We conclude that implementing D-dimer and quantitative cap-
nometry into standard daily prehospital care of acute dyspnea
exerted a beneficial effort on the PE diagnosis and the eventu-
ally need for immediately treatment. However, the diagnostic
accuracy of these methods should be confirmed in a larger
multicenter study in the field (in combination with the point-of-
Figure 2
Receiver-operator characteristics (ROC) curve for end-tidal carbon dioxide Receiver-operator characteristics (ROC) curve for end-tidal carbon dioxide.Critical Care    Vol 13 No 6    Rumpf et al.
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care prehospital ultrasound) for determination of whether
these findings can be safely incorporated.
In conclusion according to the results of our study, PetCO2
measurement has been demonstrated as a useful adjunct to
standard clinical evaluation and identification of PE in patients
with positive D-dimer tests in the prehospital setting. The com-
bination of clinical assessment and PetCO2 measurement in
patients with low clinical probability (PE unlikely) has better
diagnostic value than D-dimer in combination with clinical
assessment. The combination of PetCO2 concentrations and
high clinical probability (PE likely) is a potentially safe method
for confirmation of PE in patients with suspected PE and pos-
itive D-dimer test in prehospital setting.
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